The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELTA.L Regulatory News (ELTA)

  • There is currently no data for ELTA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Epiris announces the sale of Audiotonix

3 Feb 2017 07:00

RNS Number : 9334V
Electra Private Equity PLC
03 February 2017
 

PRESS RELEASE

3 February 2017

 

 

Epiris announces the sale of Audiotonix

 

Epiris is pleased to announce that it has agreed the sale of Audiotonix, a leading manufacturer of audio mixing consoles, to Astorg, a leading European private equity firm. The transaction is anticipated to close in the first quarter of 2017, subject to regulatory approvals.

 

Electra Private Equity PLC ("Electra") is expected to receive proceeds from the sale of £203 million, an uplift of £62 million or 44% and equivalent to an increase in its NAV of 133 pence per share on the valuation of the investment at 30 September 2016. This equates to a return of 4.8x original cost* and an IRR of 51%, assuming completion by the end of March.

 

Audiotonix is the global market leader in the design and manufacture of audio mixing consoles for live events and broadcast sound. Its three premium brands (Allen & Heath, Calrec and DiGiCo) support live sound for a variety of purposes such as concerts, TV broadcasting, theatre shows and major international live events.

 

Epiris initially invested £42 million on Electra's behalf in the acquisition of Allen & Heath in 2013. This was followed by the acquisition of Calrec in March 2014 and a merger with DiGiCo in August of that year to form Audiotonix. Epiris had identified both Calrec and DiGiCo as add-on opportunities prior to investing in Allen & Heath. These three transactions have created a market leader with a strong growth profile.

 

Charles Elkington, Partner at Epiris, said:

 

"This has been a fantastic deal for Epiris and its investors, and clearly demonstrates our strategy in action.

 

"Through structured investment across three valuable brands we have created a global market leader with strong growth prospects. When we made the initial investment we had a clear strategy based on M&A, operational improvement and strategic focus. We have delivered this with two add-on acquisitions, a reorganised supply chain, and successful investment in sales and marketing as well as new product development. As a result the business has more than quadrupled earnings since 2013.

 

"The management team, under James Gordon's passionate and insightful leadership, is exceptional and we wish them all the best for the future."

 

James Gordon, CEO of Audiotonix, said:

 

"Epiris have been an extremely supportive and engaged partner. Their vision and leadership in combining the three businesses and subsequent contribution to the evolution of the group has been invaluable. We now have a solid foundation from which to push into the next stage of our development."

 

Charles Elkington and Ian Wood are responsible for the investment and the exit of Audiotonix. Robert W. Baird advised on the sale with Taylor Wessing providing legal advice.

 

Epiris refers to Epiris Managers LLP acting on behalf of its client Electra Private Equity PLC.

 

Ends 

 

 

 

For further information please contact:

Andrew Honnor, Matthew Goodman, Matthieu Roussellier, Greenbrook Communications +44 (0)20 7952 2000

Nicholas Board and Andrew Kenny, Epiris +44 (0)20 7306 3902

 

 

Note to Editors:

 

About Epiris

Epiris is a top-decile private equity fund manager*.

 

Epiris, together with its predecessor firms, has managed the business and affairs of Electra Private Equity PLC, a listed private equity investment trust, for four decades. Epiris has also managed private equity investment programmes for pension funds, financial institutions and family offices. During this time Epiris has invested in excess of £5 billion in over 200 deals. As at 30 September 2016, the firm had funds under management of

£2.4 billion.

 

Epiris' flexible investment strategy has allowed it to invest broadly across the private equity market, including in buyouts and co-investments, secondaries and debt assets.

 

In respect of buyouts and co-investments and loan-to-own debt investments made since 2011, Epiris has delivered a gross IRR of 37%**.

 

For further information please visit www.epiris.co.uk.

 

Issued by Epiris Managers LLP which is authorised and regulated by the Financial Conduct Authority.

 

* Refers to the 2009 and 2012 investment pools comprising Buyout & Co-investment, Secondary and Debt investments managed on behalf of Electra Private Equity PLC; comparator data supplied by Preqin.

 

** As at 30 September 2016 adjusted for subsequent investments and realisations. Gross IRR does not reflect adjustments for investment management and administration costs. Past performance is no guarantee of future results.

 

About Astorg

Astorg is a European private equity firm with total funds under management of over €4 billion. Astorg seeks to partner with entrepreneurial management teams to acquire European companies and create value through the provision of strategic guidance, experienced governance and adequate capital. Astorg enjoys a distinct entrepreneurial culture, a long-term shareholder perspective, and a lean decision-making body enhancing its reactivity. Though not specialized, Astorg has gathered a valuable industry expertise in healthcare, business-to-business professional services, and technology-based industrial companies. Astorg has offices in London, Paris and Luxembourg, plus Senior Advisors based in Zurich and Frankfurt.

 

For further information about Astorg, please visit www.astorg.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISEAFAAEDKXEAF
Date   Source Headline
16th Jun 20217:00 amRNSTrading update and company announcement
14th Jun 202110:58 amRNSHalf-year Report
1st Jun 20218:00 amRNSTotal Voting Rights
28th May 202110:39 amRNSAnalyst Note produced by HSBC Global Research
26th May 202110:01 amRNSEdison issues update on Electra Private Equity
24th May 20212:26 pmRNSReplacement: Holding(s) in Company
24th May 20211:41 pmRNSHolding(s) in Company
24th May 20211:27 pmRNSDirector/PDMR Shareholding
24th May 20211:27 pmRNSDirector/PDMR Shareholding
24th May 20217:00 amRNSIssue of Equity
21st May 20211:00 pmRNS2021 Half Year Report Supplementary Information
21st May 20217:00 amRNSHalf-year Report
19th Apr 20217:00 amRNSEdison issues update on Electra Private Equity
15th Apr 20217:00 amRNSDisposal of Sentinel and Portfolio Trading Update
13th Apr 20214:41 pmRNSSecond Price Monitoring Extn
13th Apr 20214:35 pmRNSPrice Monitoring Extension
22nd Mar 20213:07 pmRNSHolding(s) in Company
19th Mar 20214:41 pmRNSSecond Price Monitoring Extn
19th Mar 20214:35 pmRNSPrice Monitoring Extension
5th Mar 20214:49 pmRNSDirector/PDMR Shareholding
4th Mar 20215:03 pmRNSDirector/PDMR Shareholding
4th Mar 202110:39 amRNSAGM Statement
3rd Mar 20215:21 pmRNSDirector/PDMR Shareholding
24th Feb 20214:45 pmRNSResult of AGM
24th Feb 20217:00 amRNSAGM Statement
26th Jan 20213:10 pmRNSAnnual Report and Notice of Annual General Meeting
17th Dec 20204:41 pmRNSEdison initiates on Electra Private Equity (ELTA)
17th Dec 20208:51 amEQSElectra Private Equity (ELTA): Innovating, restructuring and realising
16th Dec 202012:10 pmRNSEdison Investment Research note
9th Dec 20207:00 amRNSFinal Results
27th Nov 20204:41 pmRNSSecond Price Monitoring Extn
27th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Nov 202010:33 amRNSPress speculation re Hotter Shoes
27th Aug 202011:37 amRNSConfirmation of Reduction of Capital
27th Aug 20207:00 amRNSExpiry of Hotter Shoes CVA Challenge Period
26th Aug 20209:08 amRNSHolding(s) in Company
29th Jul 202011:29 amRNSDirector/PDMR Shareholding
29th Jul 20207:00 amRNSCompany update including outcome of Hotter CVA
19th Jun 20202:41 pmRNSHotter Shoes Restructure
19th Jun 20201:33 pmRNSResult of General Meeting
12th Jun 20202:44 pmRNSHalf-year Report
22nd May 20205:02 pmRNSDirector/PDMR Shareholding
21st May 20207:00 amRNSNotice of General Meeting re reduction of capital
21st May 20207:00 amRNSHalf-year Report
1st May 20202:14 pmRNSDisclosure of rights attached to equity shares
20th Mar 20207:00 amRNSUpdate in respect of the COVID-19 situation
18th Mar 20204:43 pmRNSSecond Price Monitoring Extn
18th Mar 20204:39 pmRNSPrice Monitoring Extension
17th Mar 202011:47 amRNSHolding(s) in Company
16th Mar 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.